COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,641,966 | -45.6% | 706,408 | -37.9% | 0.00% | -40.0% |
| Q2 2023 | $4,855,622 | -28.9% | 1,137,148 | +13.9% | 0.01% | -28.6% |
| Q1 2023 | $6,828,905 | +19.8% | 998,378 | +38.7% | 0.01% | +16.7% |
| Q4 2022 | $5,701,022 | -0.4% | 719,826 | +20.9% | 0.01% | -14.3% |
| Q3 2022 | $5,723,000 | +44.6% | 595,544 | +8.9% | 0.01% | +40.0% |
| Q2 2022 | $3,958,000 | -16.2% | 546,665 | +49.4% | 0.01% | +25.0% |
| Q1 2022 | $4,723,000 | +209.3% | 365,787 | +282.4% | 0.00% | +300.0% |
| Q4 2021 | $1,527,000 | +112.7% | 95,665 | +114.2% | 0.00% | 0.0% |
| Q3 2021 | $718,000 | -45.3% | 44,667 | -52.9% | 0.00% | 0.0% |
| Q2 2021 | $1,312,000 | -66.7% | 94,862 | -64.8% | 0.00% | -75.0% |
| Q1 2021 | $3,939,000 | -20.1% | 269,633 | -4.9% | 0.00% | 0.0% |
| Q4 2020 | $4,929,000 | -54.2% | 283,570 | -51.7% | 0.00% | -63.6% |
| Q3 2020 | $10,759,000 | -28.3% | 586,634 | -30.2% | 0.01% | -38.9% |
| Q2 2020 | $15,012,000 | -35.8% | 840,519 | -41.7% | 0.02% | -50.0% |
| Q1 2020 | $23,392,000 | +17.6% | 1,442,143 | +30.6% | 0.04% | +56.5% |
| Q4 2019 | $19,887,000 | +159.8% | 1,104,512 | +192.3% | 0.02% | +155.6% |
| Q3 2019 | $7,656,000 | +36.5% | 377,865 | +48.9% | 0.01% | +28.6% |
| Q2 2019 | $5,607,000 | +34.2% | 253,723 | -17.2% | 0.01% | +40.0% |
| Q1 2019 | $4,178,000 | +22.1% | 306,274 | -19.0% | 0.01% | 0.0% |
| Q4 2018 | $3,422,000 | -27.6% | 378,173 | +32.1% | 0.01% | -16.7% |
| Q3 2018 | $4,724,000 | +209.0% | 286,325 | +162.2% | 0.01% | +200.0% |
| Q2 2018 | $1,529,000 | +815.6% | 109,183 | +621.1% | 0.00% | – |
| Q1 2018 | $167,000 | -50.3% | 15,141 | -60.3% | 0.00% | – |
| Q4 2017 | $336,000 | -76.5% | 38,106 | -64.4% | 0.00% | -100.0% |
| Q3 2017 | $1,429,000 | -16.5% | 107,021 | -10.3% | 0.00% | -33.3% |
| Q2 2017 | $1,711,000 | -74.7% | 119,300 | -62.7% | 0.00% | -75.0% |
| Q1 2017 | $6,757,000 | +75.9% | 319,470 | +134.1% | 0.01% | +71.4% |
| Q4 2016 | $3,841,000 | +41.1% | 136,458 | +34.2% | 0.01% | +40.0% |
| Q3 2016 | $2,723,000 | – | 101,673 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |